Letter to the Hon. Norman Sharpless, Acting Commissioner of the Food and Drug Administration - Foster, Casten Lead Letter to FDA on Ethylene Oxide Alternatives
Letter
Date: April 22, 2019
Location: Washington, DC
Issues: Health and Health Care